alzheimer’s

George Church describes the leading edge of biotechnology. He described antiaging and gene reading and writing capabilities. George Church Described Other Leading Edge Biotechnology They are closer to making organoids in days and they are vascularized. Having veins will enable …

In mouse models of Alzheimer’s disease, the drug candidates (CMS121 and J147) improve memory and slow the degeneration of brain cells. Researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain …

Samumed has raised $438 million with a $12 billion valuation. Samumed is a leader in medical research and development for tissue-level regeneration. They have a biotechnology platform based on small molecule-based Wnt pathway modulation, they develop therapeutics to address a …

United Neuroscience (UNS) endobody vaccines train the body to develop its own defense against agents of chronic disease. Vaccines have been one of the most effective and impactful medicines in history. Vaccines historically target exogenous pathogens outside the body associated …

Scientists at Wake Forest Baptist Medical Center and the University of Southern California (USC) have demonstrated the successful implementation of a prosthetic system that uses a person’s own memory patterns to facilitate the brain’s ability to encode and recall memory. …

Bill Gates has personally invested $50 million in the Dementia Discovery Fund—a private fund working to diversify the clinical pipeline and identify new targets for treatment. Most of the major pharmaceutical companies continue to pursue the amyloid and tau pathways. …

DARPA is asking for industry’s help in developing a agile and mobile drone-defense system that can defeat a raid of self-guided, small unmanned aerial systems (UAS) that are attacking an important moving target like a high-value convoy. The potential $63 …